Qlaris Bio
- Business Model
- B2B
- Website
- qlaris.bio
- Total Funding
- $49.0M
- Last Round
- $24.0M Series BMay 2024
- Rounds
- 2
About
Clinical-stage biotechnology company developing innovative first-in-class therapies, including QLS-101 formulation.
Summary
Qlaris Bio is a Biotech company. It has raised $49.0M in total across 2 rounds, most recently a $24.0M Series B round in May 2024. Investors include Canaan Partners, New Leaf Venture Partners and abrdn.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...